Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Artemisia annua pollen drops for pediatric allergic rhinitis
CTR20190135Phase 3Completed
- Sponsor
- Wolwo Biotech
- Start
- Mar 2019
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of huanghuahao pollen drops in seasonal allergic rhinitis (SAR), sponsored by Wolwo Biotech. Started Mar 2019; status: completed.
02
Drugs
huanghuahao pollen drops
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on CTR20190135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190135.